Works matching IS 10171606 AND DT 2023
1
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 717
- Article
2
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 707
- Article
3
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 553
- Article
4
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 551
- Article
5
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 189
- Article
6
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 47
- Article
7
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 41
- Article
8
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, n. 132, p. 9
- Article
9
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 593
- Article
10
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 581
- Article
11
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 539
- Article
12
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 357
- Article
13
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 49
- Article
14
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 41
- Article
15
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 9
- Article
16
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 3
- Article
17
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2023, v. 131, p. 1
- Article